Visiongain

LONDON, UK. 22nd July 2013: With global smartphone sales poised to pass feature phones, and the tablet market showing no signs of slowing, mobile broadband has become more necessity than luxury.

LONDON, UK. 18th July 2013: Visiongain’s analysis indicates that the total value of the global small cells market revenues reach $640.8 million by the end of 2013, fuelled by an ever increasing demand for ubiquitous access to mobile broadband.

Visiongain predicts the world biosimilar monoclonal antibody market will generate $3,229m in 2018. That drug industry earned $61.88m in 2012, according to Biosimilar Monoclonal Antibodies: World Market Prospects 2013-2023, published in July 2013.

Visiongain describes the 2012 merger of Actavis and Watson as the key recent development in the world generic drugs industry. The enlarged Actavis has also acquired Warner Chilcott, cementing its place alongside the generics market leader.

LONDON, 15th July 2013: Visiongain’s analysis indicates the global automotive infotainment technologies market will be worth $31.72bn in 2013, as the market evolves through consumer demand, technological advances and integration of smart devices

Visiongain forecasts stronger growth for these market leaders between 2013 and 2023, with revenue growing at a higher rate than for the contract manufacturing market as a whole.

Visiongain’s analysis indicates that the explosive trace detection technologies market will reach a value of $830m in 2013, as governments seek to recapitalize old assets and procure new ones to cover screening requirements.

Growth in the composites market will largely be driven by the emerging markets as their technical capacity to produce such goods increase in line with the industries need for such materials.

Visiongain’s report, The 20 Leading Companies in the Natural Gas Market 2013:Competitive Landscape Analysis,profiles the major players in the natural gas market, analysing their current involvement in the market and assessing their future prospects

A new report by visiongain predicts the world market for microfluidics will reach $3.5 billion in 2017. That forecast and others appear in Microfluidic Technologies: Biopharmaceutical and Healthcare Applications 2013-2023 published in June 2013.